Warning: The NCBI web site requires JavaScript to function. more...
Fetching bibliography...
Generate a file for use with external citation management software.
[The interesting anti-H1 effects in maintenance insomnia: A reflection on the comparative advantages of doxylamine and doxepin].
Dupuis G, Vaugeois JM.
Encephale. 2019 Mar 14. pii: S0013-7006(19)30046-6. doi: 10.1016/j.encep.2019.01.006. [Epub ahead of print] French.
Similar articles
An integrated functional and transcriptomic analysis reveals that repeated exposure to diesel exhaust induces sustained mitochondrial and cardiac dysfunctions.
Karoui A, Crochemore C, Mulder P, Preterre D, Cazier F, Dewaele D, Corbière C, Mekki M, Vendeville C, Richard V, Vaugeois JM, Fardel O, Sichel F, Lecureur V, Monteil C.
Environ Pollut. 2019 Mar;246:518-526. doi: 10.1016/j.envpol.2018.12.049. Epub 2018 Dec 17.
Caffeine Reverts Memory But Not Mood Impairment in a Depression-Prone Mouse Strain with Up-Regulated Adenosine A2A Receptor in Hippocampal Glutamate Synapses.
Machado NJ, Simões AP, Silva HB, Ardais AP, Kaster MP, Garção P, Rodrigues DI, Pochmann D, Santos AI, Araújo IM, Porciúncula LO, Tomé ÂR, Köfalvi A, Vaugeois JM, Agostinho P, El Yacoubi M, Cunha RA, Gomes CA.
Mol Neurobiol. 2017 Mar;54(2):1552-1563. doi: 10.1007/s12035-016-9774-9. Epub 2016 Feb 9.
Enhanced Cocaine-Associated Contextual Learning in Female H/Rouen Mice Selectively Bred for Depressive-Like Behaviors: Molecular and Neuronal Correlates.
Rappeneau V, Morel AL, El Yacoubi M, Vaugeois JM, Denoroy L, Bérod A.
Int J Neuropsychopharmacol. 2015 Mar 2;18(8). pii: pyv022. doi: 10.1093/ijnp/pyv022.
Subsarcolemmal and interfibrillar mitochondria display distinct superoxide production profiles.
Crochemore C, Mekki M, Corbière C, Karoui A, Noël R, Vendeville C, Vaugeois JM, Monteil C.
Free Radic Res. 2015 Mar;49(3):331-7. doi: 10.3109/10715762.2015.1006212. Epub 2015 Feb 17.
GABAB(1) receptor subunit isoforms differentially regulate stress resilience.
O'Leary OF, Felice D, Galimberti S, Savignac HM, Bravo JA, Crowley T, El Yacoubi M, Vaugeois JM, Gassmann M, Bettler B, Dinan TG, Cryan JF.
Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):15232-7. doi: 10.1073/pnas.1404090111. Epub 2014 Oct 6.
The H/Rouen mouse model displays depression-like and anxiety-like behaviors.
El Yacoubi M, Rappeneau V, Champion E, Malleret G, Vaugeois JM.
Behav Brain Res. 2013 Nov 1;256:43-50. doi: 10.1016/j.bbr.2013.07.048. Epub 2013 Aug 6.
Hippocampal group III mGlu receptor mRNA levels are not altered in specific mouse models of stress, depression and antidepressant action.
O'Connor RM, Pusceddu MM, O'Leary OF, Savignac HM, Bravo JA, El Yacoubi M, Vaugeois JM, Dinan TG, Cryan JF.
Pharmacol Biochem Behav. 2013 Jan;103(3):561-7. doi: 10.1016/j.pbb.2012.09.017. Epub 2012 Oct 8.
Characterization of an mGluR2/3 negative allosteric modulator in rodent models of depression.
Campo B, Kalinichev M, Lambeng N, El Yacoubi M, Royer-Urios I, Schneider M, Legrand C, Parron D, Girard F, Bessif A, Poli S, Vaugeois JM, Le Poul E, Celanire S.
J Neurogenet. 2011 Dec;25(4):152-66. doi: 10.3109/01677063.2011.627485.
Chronic agomelatine and fluoxetine induce antidepressant-like effects in H/Rouen mice, a genetic mouse model of depression.
El Yacoubi M, Dubois M, Gabriel C, Mocaër E, Vaugeois JM.
Pharmacol Biochem Behav. 2011 Dec;100(2):284-8. doi: 10.1016/j.pbb.2011.08.001. Epub 2011 Aug 5.
Genetic association between helpless trait and depression-related phenotypes: evidence from crossbreeding studies with H/Rouen and NH/Rouen mice.
El Yacoubi M, Popa D, Martin B, Zimmer L, Hamon M, Adrien J, Vaugeois JM.
Int J Neuropsychopharmacol. 2012 Apr;15(3):363-74. doi: 10.1017/S1461145711000605. Epub 2011 May 3.
Behaviour of a genetic mouse model of depression in the learned helplessness paradigm.
Bougarel L, Guitton J, Zimmer L, Vaugeois JM, El Yacoubi M.
Psychopharmacology (Berl). 2011 Jun;215(3):595-605. doi: 10.1007/s00213-011-2218-3. Epub 2011 Feb 22.
Adenosine A2A receptor deficient mice are partially resistant to limbic seizures.
El Yacoubi M, Ledent C, Parmentier M, Costentin J, Vaugeois JM.
Naunyn Schmiedebergs Arch Pharmacol. 2009 Sep;380(3):223-32. doi: 10.1007/s00210-009-0426-8. Epub 2009 Jun 2.
Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.
Cunha RA, Ferré S, Vaugeois JM, Chen JF.
Curr Pharm Des. 2008;14(15):1512-24. Review.
Evidence for the involvement of the adenosine A(2A) receptor in the lowered susceptibility to pentylenetetrazol-induced seizures produced in mice by long-term treatment with caffeine.
Neuropharmacology. 2008 Jul;55(1):35-40. doi: 10.1016/j.neuropharm.2008.04.007. Epub 2008 Apr 18.
Genetic rodent models of depression.
El Yacoubi M, Vaugeois JM.
Curr Opin Pharmacol. 2007 Feb;7(1):3-7. Epub 2006 Dec 13. Review.
Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype.
Heurteaux C, Lucas G, Guy N, El Yacoubi M, Thümmler S, Peng XD, Noble F, Blondeau N, Widmann C, Borsotto M, Gobbi G, Vaugeois JM, Debonnel G, Lazdunski M.
Nat Neurosci. 2006 Sep;9(9):1134-41. Epub 2006 Aug 13.
Behavioral characterization of CD26 deficient mice in animal tests of anxiety and antidepressant-like activity.
El Yacoubi M, Vaugeois JM, Marguet D, Sauze N, Guieu R, Costentin J, Fenouillet E.
Behav Brain Res. 2006 Aug 10;171(2):279-85. Epub 2006 May 18.
Alterations in 5-HT1B receptor function by p11 in depression-like states.
Svenningsson P, Chergui K, Rachleff I, Flajolet M, Zhang X, El Yacoubi M, Vaugeois JM, Nomikos GG, Greengard P.
Science. 2006 Jan 6;311(5757):77-80.
Homeostatic regulation of sleep in a genetic model of depression in the mouse: effects of muscarinic and 5-HT1A receptor activation.
Popa D, El Yacoubi M, Vaugeois JM, Hamon M, Adrien J.
Neuropsychopharmacology. 2006 Aug;31(8):1637-46. Epub 2005 Nov 9.
Filters: Manage Filters